NP9-22684-41878
2 vaccinations
4 coded responses
22 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 775 / TX
- Registered
- 2022-12-22
- Relationship
- Child or adolescent in my care
- Guardian
- 7CA-12944-14627
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-21
Dose 1 — Moderna
-
2022-12-22
Registered in v-safe
- 2022-12-22
- 2022-12-23
-
2022-12-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-12-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-12-26
- 2022-12-27
- 2022-12-28
-
2023-01-04
Survey response — day 14, dose 1, under 3MedDRA: Cough, Discharge, Pyrexia — Feeling: FairMedDRA releases: 2024-11
- 2023-01-11
-
2023-01-18
Dose 2 — Moderna
- 2023-01-19
- 2023-01-20
- 2023-01-21
- 2023-01-22
- 2023-01-23
- 2023-01-24
- 2023-01-25
- 2023-02-01
-
2023-02-08
Survey response — day 21, dose 2, under 3MedDRA: Insomnia, Nasal congestion, Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
-
2023-02-15
Survey response — day 28, dose 2, under 3MedDRA: Crying, Emotional distress, Feeling hot, Nasopharyngitis, Poor quality sleep, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-02-23
Survey response — day 35, dose 2, under 3MedDRA: Ear infection, Influenza, Irritability, Poor quality sleep, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-23
Report sent to call center — day 35, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-01
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-21 | Moderna | No |
| 2 | 2023-01-18 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-23 | Successful 2023-02-23 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Crying | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Emotional distress | · | · | ✓ |
| SD | Feeling hot | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Poor quality sleep | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release